EdgarLookup

Apimeds Pharmaceuticals US, Inc. — All Filings

106 total filings on record

Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.

Overview All Filings Financials Insiders
All 10-K 10-K/A 10-Q 3 3/A 4 4/A 424B4 425 8-A12B 8-K 8-K/A CERT CORRESP DEFM14C DRS DRS/A DRSLTR EFFECT FWP NT 10-K NT 10-Q POS AM PREM14C S-1 S-1/A S-8 SCHEDULE 13D SCHEDULE 13D/A SCHEDULE 13G UPLOAD
Form Description Accession Number Filed Period
8-K CURRENT REPORT 0001213900-26-034786 Mar 26, 2026 Mar 20, 2026
8-K CURRENT REPORT 0001213900-26-033832 Mar 25, 2026 Mar 20, 2026
SCHEDULE 13D/A 0001213900-26-032480 Mar 20, 2026
8-K CURRENT REPORT 0001213900-26-028332 Mar 16, 2026
DEFM14C INFORMATION STATEMENT 0001213900-26-020883 Feb 27, 2026
425 AMENDMENT NO. 2 TO FORM 8-K 0001213900-26-017331 Feb 17, 2026
8-K/A AMENDMENT NO. 2 TO FORM 8-K 0001213900-26-017323 Feb 17, 2026 Dec 1, 2025
SCHEDULE 13G 0001493152-26-006136 Feb 11, 2026
SCHEDULE 13D/A 0001213900-26-007438 Jan 26, 2026
PREM14C INFORMATION STATEMENT 0001213900-26-005174 Jan 16, 2026
8-K CURRENT REPORT 0001213900-26-000464 Jan 2, 2026 Dec 30, 2025
8-K CURRENT REPORT 0001213900-25-119894 Dec 10, 2025 Dec 5, 2025
8-K/A AMENDMENT NO. 1 TO FORM 8-K 0001213900-25-119893 Dec 10, 2025 Dec 1, 2025
425 CURRENT REPORT 0001213900-25-117176 Dec 2, 2025
8-K CURRENT REPORT 0001213900-25-117173 Dec 2, 2025 Dec 1, 2025
4/A PRIMARY DOCUMENT 0002057997-25-000002 Nov 21, 2025 May 12, 2024
8-K CURRENT REPORT 0001213900-25-112184 Nov 18, 2025 Nov 13, 2025
4 PRIMARY DOCUMENT 0002040378-25-000004 Nov 13, 2025 Nov 11, 2025
4 PRIMARY DOCUMENT 0002041300-25-000003 Nov 13, 2025 Nov 11, 2025
4 PRIMARY DOCUMENT 0002041972-25-000004 Nov 13, 2025 Nov 11, 2025
4 PRIMARY DOCUMENT 0001573840-25-000003 Nov 13, 2025 Nov 11, 2025
4 PRIMARY DOCUMENT 0001679971-25-000008 Nov 13, 2025 Nov 11, 2025
10-Q QUARTERLY REPORT 0001213900-25-109280 Nov 12, 2025 Sep 30, 2025
4 PRIMARY DOCUMENT 0001679971-25-000007 Oct 24, 2025 Oct 15, 2025
4 PRIMARY DOCUMENT 0001573840-25-000002 Oct 21, 2025 Oct 15, 2025
4 PRIMARY DOCUMENT 0002041972-25-000003 Oct 17, 2025 Oct 15, 2025
4 PRIMARY DOCUMENT 0002040378-25-000003 Oct 17, 2025 Oct 15, 2025
4 PRIMARY DOCUMENT 0002040022-25-000002 Oct 17, 2025 Oct 15, 2025
4 PRIMARY DOCUMENT 0002041300-25-000002 Oct 17, 2025 Oct 15, 2025
4 PRIMARY DOCUMENT 0001710496-25-000002 Oct 17, 2025 Oct 15, 2025
8-K CURRENT REPORT 0001213900-25-099553 Oct 16, 2025 Oct 15, 2025
10-Q QUARTERLY REPORT 0001213900-25-078507 Aug 19, 2025 Jun 30, 2025
NT 10-Q NOTIFICATION OF LATE FILING 0001213900-25-076640 Aug 14, 2025 Jun 30, 2025
8-K CURRENT REPORT 0001213900-25-064446 Jul 16, 2025 Jul 15, 2025
4/A PRIMARY DOCUMENT 0001474506-25-000109 Jun 11, 2025 May 12, 2025
3/A PRIMARY DOCUMENT 0001474506-25-000108 Jun 11, 2025 Mar 4, 2025
8-K CURRENT REPORT 0001213900-25-051567 Jun 5, 2025 May 30, 2025
S-8 REGISTRATION STATEMENT 0001213900-25-047373 May 23, 2025
4 PRIMARY DOCUMENT 0001474506-25-000103 May 20, 2025 May 16, 2025
4 PRIMARY DOCUMENT 0001474506-25-000102 May 20, 2025 May 16, 2025
4 PRIMARY DOCUMENT 0001474506-25-000101 May 20, 2025 May 16, 2025
4 PRIMARY DOCUMENT 0001474506-25-000100 May 20, 2025 May 16, 2025
4 PRIMARY DOCUMENT 0001474506-25-000099 May 20, 2025 May 16, 2025
4 PRIMARY DOCUMENT 0002040378-25-000001 May 20, 2025 May 16, 2025
4 PRIMARY DOCUMENT 0002041972-25-000001 May 20, 2025 May 16, 2025
8-K CURRENT REPORT 0001213900-25-045643 May 20, 2025 May 16, 2025
10-Q QUARTERLY REPORT 0001213900-25-045588 May 20, 2025 Mar 31, 2025
SCHEDULE 13D 0001213900-25-045604 May 19, 2025
4 PRIMARY DOCUMENT 0001474506-25-000096 May 15, 2025 May 13, 2025
NT 10-Q NOTIFICATION OF LATE FILING 0001213900-25-044254 May 15, 2025 Mar 31, 2025